scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1030578981 |
P356 | DOI | 10.1385/EP:14:4:375 |
P698 | PubMed publication ID | 14739494 |
P2093 | author name string | Andreas Weinhäusel | |
Alois Gessl | |||
Bruce A J Ponder | |||
Roswitha Pfragner | |||
Oskar A Haas | |||
Heinrich Vierhapper | |||
Bruno Niederle | |||
Annemarie Behmel | |||
P2860 | cites work | Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease | Q28305753 |
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. | Q31928758 | ||
The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome. | Q33590925 | ||
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas | Q33682913 | ||
RET proto-oncogene in the development of human cancer | Q33718087 | ||
Pheochromocytoma: inherited associations, bilaterality, and cortex preservation | Q34103572 | ||
Germ-line mutations in nonsyndromic pheochromocytoma | Q34523021 | ||
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease | Q34726998 | ||
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas | Q40853448 | ||
First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells | Q40905421 | ||
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis | Q40920116 | ||
A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene | Q40922879 | ||
Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma | Q40980321 | ||
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease. | Q41021579 | ||
Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease | Q41091439 | ||
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. | Q41180363 | ||
Germline mutation of RET codon 883 in two cases of de novo MEN 2B. | Q48045271 | ||
Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)". | Q50752866 | ||
Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. | Q50890372 | ||
Pheochromocytoma in multiple endocrine neoplasia type 2: European study | Q62978347 | ||
A RET double mutation in the germline of a kindred with FMTC. | Q64992218 | ||
Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene | Q71540782 | ||
The RET proto-oncogene in sporadic pheochromocytomas | Q71603189 | ||
Expression of the ret proto-oncogene in phaeochromocytoma. An in situ hybridization and northern blot study | Q71895470 | ||
Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases | Q72225417 | ||
A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A | Q73211985 | ||
[Pheochromocytoma associated with multiple endocrine neoplasia 2A and sporadic: differential characteristics] | Q73229941 | ||
Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas | Q73263319 | ||
Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance | Q73330043 | ||
Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas | Q73336672 | ||
A patient with MEN 2 and multiple mutations of RET in the germline | Q73375001 | ||
Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas | Q73377914 | ||
Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene | Q73941283 | ||
Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A | Q74127739 | ||
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A | Q74324586 | ||
Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas | Q77371914 | ||
P433 | issue | 4 | |
P921 | main subject | phaeochromocytoma | Q536269 |
multiple endocrine neoplasia | Q1553018 | ||
P304 | page(s) | 375-382 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Endocrine Pathology | Q15757049 |
P1476 | title | Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman | |
P478 | volume | 14 |
Q37587164 | Neuroendocrine tumors and tumor syndromes in childhood |
Q49852319 | Pathology and genetics of phaeochromocytoma and paraganglioma |
Q36712963 | Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. |
Q33842300 | Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. |
Search more.